Cambridge Cognition Holdings Plc, a neuroscience technology company, develops digital health solutions in the United States, United Kingdom, the European Union, and internationally. More Details
Excellent balance sheet with weak fundamentals.
Share Price & News
How has Cambridge Cognition Holdings's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: COG is more volatile than 75% of UK stocks over the past 3 months, typically moving +/- 11% a week.
Volatility Over Time: COG's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of UK stocks.
7 Day Return
GB Healthcare Services
1 Year Return
GB Healthcare Services
Return vs Industry: COG exceeded the UK Healthcare Services industry which returned 75.8% over the past year.
Return vs Market: COG exceeded the UK Market which returned 26.5% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Cambridge Cognition Holdings's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall StShareholders Are Raving About How The Cambridge Cognition Holdings (LON:COG) Share Price Increased 502%
3 months ago | Simply Wall StCambridge Cognition Holdings (LON:COG) Is In A Good Position To Deliver On Growth Plans
7 months ago | Simply Wall StWe're Not Very Worried About Cambridge Cognition Holdings' (LON:COG) Cash Burn Rate
Is Cambridge Cognition Holdings undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate COG's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate COG's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: COG is unprofitable, so we can't compare its PE Ratio to the XE Healthcare Services industry average.
PE vs Market: COG is unprofitable, so we can't compare its PE Ratio to the UK market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate COG's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: COG is overvalued based on its PB Ratio (710x) compared to the GB Healthcare Services industry average (6.6x).
How is Cambridge Cognition Holdings forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Forecasted Healthcare industry annual growth in earnings
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if COG's forecast earnings growth is above the savings rate (0.9%).
Earnings vs Market: Insufficient data to determine if COG's earnings are forecast to grow faster than the UK market
High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if COG's revenue is forecast to grow faster than the UK market.
High Growth Revenue: Insufficient data to determine if COG's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if COG's Return on Equity is forecast to be high in 3 years time
How has Cambridge Cognition Holdings performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: COG is currently unprofitable.
Growing Profit Margin: COG is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: COG is unprofitable, and losses have increased over the past 5 years at a rate of 35.3% per year.
Accelerating Growth: Unable to compare COG's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: COG is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (8.6%).
Return on Equity
High ROE: COG has a negative Return on Equity (-768.42%), as it is currently unprofitable.
How is Cambridge Cognition Holdings's financial position?
Financial Position Analysis
Short Term Liabilities: COG's short term assets (£5.7M) do not cover its short term liabilities (£6.2M).
Long Term Liabilities: COG has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: COG is debt free.
Reducing Debt: COG has not had any debt for past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable COG has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: COG is unprofitable but has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by 9.5% per year.
What is Cambridge Cognition Holdings's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate COG's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate COG's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if COG's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if COG's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of COG's dividend in 3 years as they are not forecast to pay a notable one for the UK market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Dr. Matthew Stork has been the Chief Executive Officer at Cambridge Cognition Holdings Plc since May 24, 2019 and has been its Director since May 23, 2019. He was Chief Operating Officer of Cambridge Cogni...
CEO Compensation Analysis
Compensation vs Market: Matthew's total compensation ($USD351.60K) is about average for companies of similar size in the UK market ($USD338.50K).
Compensation vs Earnings: Insufficient data to compare Matthew's compensation with company performance.
Experienced Management: COG's management team is considered experienced (4.8 years average tenure).
Experienced Board: COG's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Cambridge Cognition Holdings Plc's company bio, employee growth, exchange listings and data sources
- Name: Cambridge Cognition Holdings Plc
- Ticker: COG
- Exchange: AIM
- Founded: 2012
- Industry: Health Care Technology
- Sector: Healthcare
- Market Cap: UK£40.365m
- Shares outstanding: 31.05m
- Website: https://www.cambridgecognition.com
Number of Employees
- Cambridge Cognition Holdings Plc
- Tunbridge Court
- Tunbridge Lane
- CB25 9TU
- United Kingdom
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops digital health solutions in the United States, United Kingdom, the European Union, and internationally. The company offers CANT...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/05/09 19:41|
|End of Day Share Price||2021/05/07 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.